Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von BTIG Research 

MacroGenics Inc. diskutieren

MacroGenics Inc.

WKN: A1W6ND / Symbol: MGNX / Name: MacroGenics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

14,20 €
4,47 %

Einschätzung Buy
Rendite (%) 122,05 %
Kursziel 11,13
Veränderung
Endet am 21.03.24

MacroGenics, Inc. (NASDAQ: MGNX) had its price target raised by analysts at BTIG Research from $6.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for MGNX provided by MarketBeat

Einschätzung Buy
Rendite (%) 140,43 %
Kursziel 12,88
Veränderung
Endet am 03.04.24

MacroGenics, Inc. (NASDAQ: MGNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Ratings data for MGNX provided by MarketBeat

MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for MGNX provided by MarketBeat

Einschätzung Buy
Rendite (%) 142,74 %
Kursziel 11,24
Veränderung
Endet am 07.11.24

MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $12.00 price target on the stock.
Ratings data for MGNX provided by MarketBeat

Einschätzung Buy
Rendite (%) 140,68 %
Kursziel 11,22
Veränderung
Endet am 13.11.24

MacroGenics, Inc. (NASDAQ: MGNX) had its price target lowered by analysts at HC Wainwright from $14.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for MGNX provided by MarketBeat

Einschätzung Buy
Rendite (%) 102,86 %
Kursziel 15,52
Veränderung
Endet am 27.11.24

MacroGenics, Inc. (NASDAQ: MGNX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $17.00 price target on the stock.
Ratings data for MGNX provided by MarketBeat

Einschätzung Buy
Rendite (%) 49,47 %
Kursziel 11,86
Veränderung
Endet am 20.12.24

MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $13.00 price target on the stock, up previously from $7.00.
Ratings data for MGNX provided by MarketBeat

Einschätzung Buy
Rendite (%) -14,46 %
Kursziel 21,20
Veränderung
Endet am 28.02.25

MacroGenics, Inc. (NASDAQ: MGNX) had its price target raised by analysts at Barclays PLC from $12.00 to $23.00. They now have an "overweight" rating on the stock.
Ratings data for MGNX provided by MarketBeat

MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating.
Ratings data for MGNX provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,53 %
Kursziel 23,32
Veränderung
Endet am 26.04.25

MacroGenics, Inc. (NASDAQ: MGNX) is now covered by analysts at B. Riley. They set a "buy" rating and a $25.00 price target on the stock.
Ratings data for MGNX provided by MarketBeat